Search research articles
Contact Us
Filters
Showing results (201-210 of 359) with videos related to
Page
of 36
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 20, 2025
Radiolabeling of CHX-A″-DTPA-Antibody Conjugates with [<sup>89</sup>Zr]ZrCl<sub>4</sub>
Serge K Lyashchenko, Tullio V Esposito, Tuan Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 15, 2026
Exploring the 89 Zr/ 177 Lu Theranostic Pairing with an Extracellular Matrix Targeted Radiopharmaceutical Against Triple Negative Breast Cancer
Justin Hachey, Tara D Viray, Sebastian E Carrasco, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 18, 2017
First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using <sup>89</sup>Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
Gary A Ulaner, Serge K Lyashchenko, Christopher Riedl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 9, 2023
<sup>212</sup>Pb-Pretargeted Theranostics for Pancreatic Cancer
David Bauer, Lukas M Carter, Mohamed I Atmane, et al.
Molecular Pharmaceutics
|
January 5, 2016
Applying ⁸⁹Zr-Transferrin To Study the Pharmacology of Inhibitors to BET Bromodomain Containing Proteins
Michael G Doran, Kathryn E Carnazza, Jeffrey M Steckler, et al.
Bioconjugate Chemistry
|
November 5, 2013
(18)F-labeled-bioorthogonal liposomes for in vivo targeting
Fabien Emmetiere, Christopher Irwin, Nerissa Therese Viola-Villegas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 14, 2024
Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer
Kyeara N Mack, Zachary V Samuels, Lukas M Carter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 4, 2016
Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis
Sai Kiran Sharma, Kuntal K Sevak, Sebastien Monette, et al.
Cancer Research
|
April 8, 2017
Multinuclear NMR and MRI Reveal an Early Metabolic Response to mTOR Inhibition in Sarcoma
Valentina Di Gialleonardo, Hannah N Aldeborgh, Vesselin Miloushev, et al.
Molecular Cancer Therapeutics
|
February 8, 2022
Noninvasive Imaging of CD4+ T Cells in Humanized Mice
Veronica L Nagle, Charli Ann J Hertz, Kelly E Henry, et al.
Page
of 36
Search research articles
Search
Showing results (201-210 of 359) with videos related to
Sort By:
Page
of 36
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 20, 2025
Radiolabeling of CHX-A″-DTPA-Antibody Conjugates with [<sup>89</sup>Zr]ZrCl<sub>4</sub>
Serge K Lyashchenko, Tullio V Esposito, Tuan Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 15, 2026
Exploring the 89 Zr/ 177 Lu Theranostic Pairing with an Extracellular Matrix Targeted Radiopharmaceutical Against Triple Negative Breast Cancer
Justin Hachey, Tara D Viray, Sebastian E Carrasco, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 18, 2017
First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using <sup>89</sup>Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
Gary A Ulaner, Serge K Lyashchenko, Christopher Riedl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 9, 2023
<sup>212</sup>Pb-Pretargeted Theranostics for Pancreatic Cancer
David Bauer, Lukas M Carter, Mohamed I Atmane, et al.
Molecular Pharmaceutics
|
January 5, 2016
Applying ⁸⁹Zr-Transferrin To Study the Pharmacology of Inhibitors to BET Bromodomain Containing Proteins
Michael G Doran, Kathryn E Carnazza, Jeffrey M Steckler, et al.
Bioconjugate Chemistry
|
November 5, 2013
(18)F-labeled-bioorthogonal liposomes for in vivo targeting
Fabien Emmetiere, Christopher Irwin, Nerissa Therese Viola-Villegas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 14, 2024
Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer
Kyeara N Mack, Zachary V Samuels, Lukas M Carter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 4, 2016
Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis
Sai Kiran Sharma, Kuntal K Sevak, Sebastien Monette, et al.
Cancer Research
|
April 8, 2017
Multinuclear NMR and MRI Reveal an Early Metabolic Response to mTOR Inhibition in Sarcoma
Valentina Di Gialleonardo, Hannah N Aldeborgh, Vesselin Miloushev, et al.
Molecular Cancer Therapeutics
|
February 8, 2022
Noninvasive Imaging of CD4+ T Cells in Humanized Mice
Veronica L Nagle, Charli Ann J Hertz, Kelly E Henry, et al.
Page
of 36